Breaking News
Just In
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pao Group Inc (OP: PAOG )

0.0003 -0.0001 (-25.00%)
Streaming Delayed Price Updated: 2:15 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pao Group Inc

PURA And PAOG To Launch CBD Product Line For Women's Health Market In April
Puration, Inc. (OTCPK:PURA) and PAO Group, Inc. (OTCPK:PAOG) are working together on a new line of CBD Nu... 
Via Benzinga
PAO Group, Inc. Expands Development Deal With Puration To Pursue Tissue Culture Technology (OTC Pink: PAOG)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
PAO Group, Inc. Stock Consolidating With 47% Gains Since October; Technicals Indicate A Move Higher After Expanding CBD Offerings (OTC Pink: PAOG)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
UC Asset LP To Provide Cannabis Real Estate Financing Via PURA Farmersville Hemp Brand COOP
UC Asset LP (OTC:UCASU) and Puration, Inc. (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Alternet Systems, Inc., PAO Group Inc., And World Series of Golf, Inc. Are Surging In October; Near Term Catalysts Make Them A Micro-Cap Power Play
Via AB Newswire
PAO Group, Inc. Launches Second CBD Nutraceutical, RehabRX; Shares Surge Triple Digit Percentages Since September (OTC Pink: PAOG)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
Puration, Inc. Stock Closes Near Four Month Highs As Partnership With PAO Group, Inc. Accelerates Move Into Hemp And CBD Sectors (OTC Other: PURA)
Via AB Newswire
PAO Group, Inc. Stock Gains 220% Since September; Announces Commercial Launch Of First CBD Nutraceuticals Product Through Partner USMJ (OTC Pink: PAOG)
Via AB Newswire
PAO Group, Inc. Approaches Revenue-Generating Milestone; Ships First CBD Nutraceuticals As Commercialization Strategy Accelerates (OTC Pink: PAOG)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
PAO Group, Inc.’s CBD-Nutraceutical Portfolio Expected To Bring Leading Solutions to a $15B Industry (OTC Pink: PAOG)
Via AB Newswire
PAO Group, Inc. Intends Get Its First CBD-Based Therapeutic To Market This Year, Targets An Unmet $18 Billion Opportunity (OTC Pink: PAOG)
Via AB Newswire
PAO Group, Inc. Confirms Highly Anticipated Line of CBD Nutraceuticals Remains on Track for a 2021 Launch (OTC Pink: PAOG)
Via AB Newswire
Access to New Production Facility Expected To Accelerate PAO Group, Inc.’s Entry Into The $5 Billion CBD Market (PAOG)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
PAO Group, Inc. Expands Its CBD Nutraceuticals Program; Three Products By EOY 2021 Targets $5 Billion Global Demand
Via AB Newswire
PAO Group, Inc.’s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs
Via AB Newswire
Topics Cannabis
Exposures Cannabis
PAO Group Teams Up With Puration, Alkame, North American Cannabis Holdings On New CBD Nutraceuticals
PAO Group, Inc. (OTC:PAOG), a holding company focused on alte... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year’s End
Via AB Newswire
Topics Cannabis
Exposures Cannabis
PAO Group, Inc. Stock Rockets 28% After Updates Point Toward Near-Term CBD-Based Nutraceutical Commercialization (PAOG)
Via AB Newswire
These Emerging Companies Have Near Term Catalysts That Could Send Share Prices Soaring
Via AB Newswire
PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment
Via AB Newswire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Here’s Why Alkame Holdings, Inc. Jumped 40% Last Week…And Why More Is Expected (ALKM)
Via AB Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.